Study to Evaluate the Efficacy and Safety of BCX7353 as an Oral Treatment for the Prevention of HAE Attacks in Japan

NCT03873116 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Hereditary Angioedema, HAE

Interventions

DRUG: BCX7353 capsules
DRUG: BCX7353 capsules
DRUG: Placebo oral capsule

Sponsor

BioCryst Pharmaceuticals